SPERO THERAPEUTICS INC (SPRO) Stock Income Statement
NASDAQ:SPRO - Nasdaq - US84833T1034 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 47.98M | 103.78M | 53.51M | 18.26M | 9.33M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 120.46M | 76.99M | 84.08M | 106.23M | 88.44M | |||
| Research and Development | 96.76M | 51.44M | 47.59M | 64.53M | 67.00M | |||
| Selling, General, and Administrative Expenses | 23.70M | 25.55M | 36.48M | 41.70M | 21.44M | |||
| Operating Income | -72.48M | 26.79M | -30.57M | -87.97M | -79.11M | |||
| Interest Income/Expense | 4.74M | 3.94M | -580.00K | -1.39M | 400.00K | |||
| Other Income/Expense | 60.00K | -14.00K | -60.00K | -400.00K | 430.00K | |||
| Non Recurring Items | -877.00K | -5.31M | -15.21M | N/A | N/A | |||
| Income Before Taxes | -68.57M | 25.40M | -46.42M | -89.76M | -78.28M | |||
| Income Tax | 0.00 | 2.60M | N/A | N/A | 0.00 | |||
| Net Income | -68.57M | 22.81M | -46.42M | -89.76M | -78.83M | |||
| EBITDA | -72.48M | 27.15M | -29.70M | -87.32M | -78.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.27 | 0.43 | -1.23 | -2.91 | -3.52 | |||
| Non GAAP EPS | -1.27 | 0.52 | -1.66 | -2.89 | -3.58 | |||
| Statistics | ||||||||
| Profit Margin | -142.91% | 21.98% | -86.75% | -491.57% | -844.91% | |||
| Operating Profit Margin | -151.08% | 25.81% | -57.13% | -481.76% | -847.91% | |||
All data in USD